William Blair & Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$298M Sell
324,018
-778
-0.2% -$789K 0.85% 20
2025
Q4
$349M Buy
324,796
+25,247
+8% +$24.1M 0.94% 16
2025
Q3
$229M Sell
299,549
-4,918
-2% -$3.66M 0.61% 37
2025
Q2
$237M Sell
304,467
-27,354
-8% -$21.3M 0.66% 37
2025
Q1
$274M Sell
331,821
-2,540
-0.8% -$2.11M 0.83% 25
2024
Q4
$258M Sell
334,361
-4,937
-1% -$4.09M 0.75% 25
2024
Q3
$301M Sell
339,298
-7,290
-2% -$6.55M 0.88% 22
2024
Q2
$314M Buy
346,588
+15,133
+5% +$12.1M 0.97% 22
2024
Q1
$258M Buy
331,455
+5,888
+2% +$4.19M 0.81% 28
2023
Q4
$190M Sell
325,567
-2,885
-0.9% -$1.68M 0.65% 37
2023
Q3
$176M Sell
328,452
-1,679
-0.5% -$865K 0.68% 34
2023
Q2
$155M Buy
330,131
+12,633
+4% +$5.3M 0.57% 41
2023
Q1
$109M Buy
317,498
+3,833
+1% +$1.29M 0.44% 56
2022
Q4
$115M Buy
313,665
+7,976
+3% +$2.83M 0.5% 49
2022
Q3
$98.8M Buy
305,689
+10,877
+4% +$3.45M 0.45% 53
2022
Q2
$95.6M Buy
294,812
+22,189
+8% +$6.66M 0.42% 55
2022
Q1
$78.1M Buy
272,623
+3,125
+1% +$804K 0.27% 89
2021
Q4
$74.4M Buy
269,498
+2,908
+1% +$737K 0.23% 103
2021
Q3
$61.6M Sell
266,590
-796
-0.3% -$196K 0.21% 109
2021
Q2
$61.4M Sell
267,386
-17,064
-6% -$3.43M 0.21% 108
2021
Q1
$53.1M Sell
284,450
-18,715
-6% -$3.66M 0.2% 119
2020
Q4
$51.2M Sell
303,165
-17,507
-5% -$2.61M 0.19% 121
2020
Q3
$47.5M Buy
320,672
+12,250
+4% +$1.9M 0.2% 105
2020
Q2
$50.6M Sell
308,422
-3,620
-1% -$556K 0.24% 90
2020
Q1
$43.3M Sell
312,042
-23,412
-7% -$3.22M 0.27% 83
2019
Q4
$44.1M Buy
335,454
+50,249
+18% +$5.82M 0.23% 100
2019
Q3
$31.9M Buy
285,205
+899
+0.3% +$100K 0.18% 118
2019
Q2
$31.5M Buy
284,306
+13,246
+5% +$1.56M 0.18% 121
2019
Q1
$35.2M Buy
271,060
+15,733
+6% +$1.91M 0.21% 110
2018
Q4
$29.5M Buy
255,327
+9,526
+4% +$1.06M 0.22% 111
2018
Q3
$26.4M Buy
245,801
+9,532
+4% +$953K 0.16% 140
2018
Q2
$20.2M Buy
236,269
+927
+0.4% +$76.1K 0.14% 159
2018
Q1
$18.2M Sell
235,342
-215,565
-48% -$17.4M 0.13% 162
2017
Q4
$38.1M Buy
450,907
+93,368
+26% +$7.94M 0.26% 98
2017
Q3
$30.6M Buy
357,539
+77,956
+28% +$6.39M 0.23% 110
2017
Q2
$23M Buy
279,583
+17,325
+7% +$1.41M 0.17% 138
2017
Q1
$22M Buy
262,258
+30,399
+13% +$2.43M 0.18% 138
2016
Q4
$17.1M Buy
231,859
+5,280
+2% +$393K 0.15% 161
2016
Q3
$18.2M Buy
226,579
+28,633
+14% +$2.29M 0.16% 160
2016
Q2
$15.6M Buy
197,946
+88,789
+81% +$6.68M 0.15% 165
2016
Q1
$7.86M Buy
109,157
+24,763
+29% +$1.87M 0.07% 225
2015
Q4
$7.11M Buy
84,394
+5,444
+7% +$452K 0.07% 242
2015
Q3
$6.61M Sell
78,950
-7
-0% -$591 0.06% 277
2015
Q2
$6.59M Sell
78,957
-6,617
-8% -$504K 0.01% 995
2015
Q1
$6.22M Buy
85,574
+492
+0.6% +$35K 0.01% 984
2014
Q4
$5.87M Buy
85,082
+1,471
+2% +$99.3K 0.01% 1007
2014
Q3
$5.42M Buy
83,611
+1,304
+2% +$82.6K 0.01% 1010
2014
Q2
$5.12M Buy
82,307
+4,184
+5% +$250K 0.01% 1000
2014
Q1
$4.6M Buy
78,123
+5,839
+8% +$326K 0.01% 995
2013
Q4
$3.69M Sell
72,284
-8,230
-10% -$412K 0.01% 997
2013
Q3
$4.05M Sell
80,514
-6,011
-7% -$315K 0.01% 954
2013
Q2
$4.25M Buy
+86,525
New +$4.71M 0.01% 908

Other funds holding LLY

William Blair & Company's LLY Position: Q1 2026 in Review

William Blair & Company reduced its Eli Lilly (LLY) stake by 0.24% in Q1 2026, selling an estimated $789K and leaving 324,018 shares worth $298M. The position accounts for 0.85% of the portfolio, ranked #20.

William Blair & Company first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $349M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • William Blair & Company held 324,018 shares of Eli Lilly worth $298M as of Q1 2026.
  • William Blair & Company sold 778 Eli Lilly shares in Q1 2026, an estimated $789K.
  • Eli Lilly made up 0.85% of William Blair & Company's portfolio in Q1 2026, its #20 holding.
  • William Blair & Company first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • William Blair & Company's Eli Lilly position peaked at $349M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.